Skip to content

Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting

Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00717613
Enrollment
50
Registered
2008-07-17
Start date
2007-07-31
Completion date
2011-10-31
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Localized Prostate Cancer

Brief summary

This study includes an interview with men who have selected watchful waiting or active surveillance for their localized prostate cancer, in lieu of active treatment (such as surgery or radiation). We hope to understand the educational and support needs of men on surveillance so that we can develop a new intervention that will improve quality of life for such men.

Detailed description

Interviews are conducted over the telephone and require approximately 90 minutes to complete. Men interviewed are compensated for their participation in the study.

Interventions

None listed

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\) male, * 2\) 18 years or older, with biopsy-proven prostate cancer, * 3\) diagnosed with localized disease within the last 24 months, * 4\) have a telephone at the time of enrollment, * 5\) have an address where they can receive study materials by mail (a street address or post office box), * 6\) able to speak and understand English; * 7\) have selected surveillance, rather than active treatment for his prostate cancer.

Exclusion criteria

* 1\) female * 2\) no diagnosis of localized prostate cancer * 3\) completed or undergoing active treatment (e.g., surgery, radiotherapy, etc.) * 4\) no phone or US mail address * 5\) unwilling or unable to provide informed consent * 6\) unable to speak and understand English

Design outcomes

Primary

MeasureTime frame
Health-related quality of life, particularly cancer-specific anxiety and general anxietyOne time retrospective interview

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026